Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2808 in Multiple System Atrophy
NCT05923866Phase 2Active, not recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ONO-2808 in multiple system atrophy (MSA), sponsored by Ono Pharmaceutical. Started Sep 2023; status: active, not recruiting.
02
Drugs
ONO-2808
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT05923866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05923866.